CM
CORZ icon

Castleark Management’s Core Scientific CORZ Stock Holding History

Castleark Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-94,131
Closed -$1.69M – 304
2025
Q3 		$1.69M Sell
94,131
-353,889
-79% -$5.19M 0.05% 206
2025
Q2 		$7.65M Buy
+448,020
New +$4.48M 0.23% 71

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Castleark Management's CORZ Position: Q4 2025 in Review

Castleark Management sold out of Core Scientific (CORZ) in Q4 2025, closing a stake of 94,131 shares — an estimated $1.69M sold.

Castleark Management first reported a position in CORZ in Q2 2025 and held it in 2 quarters. The position peaked at $7.65M in Q2 2025. 367 funds tracked by Wall St. Rank hold CORZ as of Q4 2025.

  • Castleark Management reported no remaining Core Scientific position as of Q4 2025 after selling out during the quarter.
  • Castleark Management sold 94,131 Core Scientific shares in Q4 2025, an estimated $1.69M.
  • Castleark Management first reported a position in Core Scientific in Q2 2025 and held it in 2 quarters.
  • Castleark Management's Core Scientific position peaked at $7.65M in Q2 2025.
  • 367 funds tracked by Wall St. Rank held Core Scientific as of Q4 2025.

Based on Castleark Management's 13F filing for Q4 2025, filed 13 Feb 2026.